Skip to main content
Premium Trial:

Request an Annual Quote

BioSource Directors Reject Bio-Rad s $82M Acquisition Bid

NEW YORK, April 12 (GenomeWeb News) - BioSource International's directors unanimously rejected Bio-Rad Laboratories' $82 million offer to acquire the company, BioSource said yesterday.


In a letter to Bio-Rad CEO Norman Schwartz, the directors said they believed that Bio-Rad's April 6 offer of $8.50 per share was "significantly below BioSource's inherent value."


The directors further noted that prior to April 6, they had already been meeting with financial advisors to evaluate "strategic alternatives, including a possible sale of the company" to maximize financial results for its stockholders.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.